{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:36:40Z","timestamp":1775705800090,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant is highly transmissible with potential immune escape. Hence, control measures are continuously being optimized to guard against large-scale coronavirus disease 2019 (COVID-19) outbreaks. This study aimed to explore the relationship between the intensity of control measures in response to different SARS-CoV-2 variants and the degree of outbreak control at city level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study was conducted in 49 cities with COVID-19 outbreaks between January 2020 and June 2022. Epidemiological data on COVID-19 were extracted from the National Health Commission, People\u2019s Republic of China, and the population flow data were sourced from the Baidu migration data provided by the Baidu platform. Outbreak control was quantified by calculating the degree of infection growth and the time-varying reproduction number (<jats:inline-formula><jats:alternatives><jats:tex-math>$${R}_{t}$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:msub>\n                      <mml:mi>R<\/mml:mi>\n                      <mml:mi>t<\/mml:mi>\n                    <\/mml:msub>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula>). The intensity of the outbreak response was quantified by calculating the reduction in population mobility during the outbreak period. Correlation and regression analyses of the intensity of the control measures and the degree of outbreak control for the Omicron variant and non-Omicron mutants were conducted, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 65 outbreaks occurred in 49 cities in China from January 2020 to June 2022. Of them, 66.2% were Omicron outbreaks and 33.8% were non-Omicron outbreaks. The intensity of the control measures was positively correlated with the degree of outbreak control (<jats:italic>r<\/jats:italic>\u2009=\u20090.351, <jats:italic>P<\/jats:italic>\u2009=\u20090.03). The degree of reduction in population mobility was negatively correlated with the <jats:italic>R<\/jats:italic><jats:sub><jats:italic>t<\/jats:italic><\/jats:sub> value (<jats:italic>r<\/jats:italic>\u2009=\u00a0\u2212\u00a00.612, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Therefore, under the same control measure intensity, the number of new daily Omicron infections was 6.04 times higher than those attributed to non-Omicron variants, and the <jats:italic>R<\/jats:italic><jats:sub><jats:italic>t<\/jats:italic><\/jats:sub> value of Omicron outbreaks was 2.6 times higher than that of non-Omicron variants. In addition, the duration of non-Omicron variant outbreaks was shorter than that of the outbreaks caused by the Omicron variant (23.0\u2009\u00b1\u200910.7, 32.9\u2009\u00b1\u200916.3, <jats:italic>t<\/jats:italic>\u2009=\u20092.243, <jats:italic>P<\/jats:italic>\u2009=\u20090.031).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Greater intensity of control measures was associated with more effective outbreak control. Thus, in response to the Omicron variant, the management to restrict population movement should be used to control its spread quickly, especially in the case of community transmission occurs widely. Faster than is needed for non-Omicron variants, and decisive control measures should be imposed and dynamically adjusted in accordance with the evolving epidemic situation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40249-022-01043-2","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T12:04:17Z","timestamp":1669377857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level"],"prefix":"10.1186","volume":"11","author":[{"given":"Jin-Xin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Guang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Yong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Lai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Yang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8929-4433","authenticated-orcid":false,"given":"Shun-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"1043_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.46234\/ccdcw2022.012","volume":"4","author":"L Wang","year":"2022","unstructured":"Wang L, Wang S, Zhang X, Jia Z. Impact of regions with COVID-19 cases on COVID-zero regions by population mobility\u2014worldwide, 2021. China CDC Wkly. 2022;4:79\u201382.","journal-title":"China CDC Wkly"},{"key":"1043_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S0140-6736(22)01585-9","volume":"400","author":"JD Sachs","year":"2022","unstructured":"Sachs JD, Karim SSA, Aknin L, Allen J, Brosb\u00f8l K, Colombo F, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022;400:1224\u201380.","journal-title":"Lancet"},{"key":"1043_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40249-022-00955-3","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Cai Y, Zhang B, Zhang X, Wang L, Yan X, et al. Cost-effectiveness analysis on COVID-19 surveillance strategy of large-scale sports competition. Infect Dis Poverty. 2022;11:32.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR4","first-page":"1438","volume":"327","author":"HD Larkin","year":"2022","unstructured":"Larkin HD. Global COVID-19 death toll may be triple the reported deaths. JAMA. 2022;327:1438.","journal-title":"JAMA"},{"key":"1043_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41562-020-0896-8","volume":"4","author":"D Guan","year":"2020","unstructured":"Guan D, Wang D, Hallegatte S, Davis SJ, Huo J, Li S, et al. Global supply-chain effects of COVID-19 control measures. Nat Hum Behav. 2020;4:577\u201387.","journal-title":"Nat Hum Behav"},{"key":"1043_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40249-022-00935-7","volume":"11","author":"JA Polonsky","year":"2022","unstructured":"Polonsky JA, Bhatia S, Fraser K, Hamlet A, Skarp J, Stopard IJ, et al. Feasibility, acceptability, and effectiveness of non-pharmaceutical interventions against infectious diseases among crisis-affected populations: a scoping review. Infect Dis Poverty. 2022;11:14.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra2206573","volume":"387","author":"DH Barouch","year":"2022","unstructured":"Barouch DH. Covid-19 vaccines\u2014immunity, variants, boosters. N Engl J Med. 2022;387:1011\u201320.","journal-title":"N Engl J Med"},{"key":"1043_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.46234\/ccdcw2022.001","volume":"4","author":"Q Guo","year":"2022","unstructured":"Guo Q, Ruhan A, Liang L, Zhao X, Deng A, Hu Y, et al. An imported case of BA.2 lineage of Omicron variant COVID-19\u2014Guangdong Province, China, December 28, 2021. China CDC Wkly. 2022;4:98\u20139.","journal-title":"China CDC Wkly"},{"key":"1043_CR9","first-page":"385","volume":"4","author":"T Hu","year":"2022","unstructured":"Hu T, Zhang M, Deng A, Zhang Y, Li B, Li Y, et al. Comparison of Omicron and Delta variant infection COVID-19 cases\u2014Guangdong Province, China, 2022. China CDC Wkly. 2022;4:385\u20138.","journal-title":"China CDC Wkly"},{"key":"1043_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2021-000040","volume":"1","author":"M Young","year":"2022","unstructured":"Young M, Crook H, Scott J, Edison P. Covid-19: virology, variants, and vaccines. BMJ Med. 2022;1: e000040.","journal-title":"BMJ Med"},{"key":"1043_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602:671\u20135.","journal-title":"Nature"},{"key":"1043_CR12","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1001\/jama.2020.20717","volume":"324","author":"A Bilinski","year":"2020","unstructured":"Bilinski A, Emanuel EJ. COVID-19 and excess all-cause mortality in the US and 18 comparison countries. JAMA. 2020;324:2100\u20132.","journal-title":"JAMA"},{"key":"1043_CR13","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2022.3780","volume":"327","author":"SB J\u00f8rgensen","year":"2022","unstructured":"J\u00f8rgensen SB, Nyg\u00e5rd K, Kacelnik O, Telle K. Secondary attack rates for Omicron and Delta variants of SARS-CoV-2 in Norwegian households. JAMA. 2022;327:1610\u20131.","journal-title":"JAMA"},{"key":"1043_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40249-022-00988-8","volume":"11","author":"B Zheng","year":"2022","unstructured":"Zheng B, Zhu W, Pan J, Wang W. Patterns of human social contact and mask wearing in high-risk groups in China. Infect Dis Poverty. 2022;11:69.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40249-022-00960-6","volume":"11","author":"J Pan","year":"2022","unstructured":"Pan J, Zhu W, Tian J, Liu Z, Xu A, Yao Y, et al. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19. Infect Dis Poverty. 2022;11:36.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR16","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41591-022-01816-0","volume":"28","author":"O Puhach","year":"2022","unstructured":"Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A, et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022;28:1491\u2013500.","journal-title":"Nat Med"},{"key":"1043_CR17","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1056\/NEJMoa2201570","volume":"386","author":"YM Bar-On","year":"2022","unstructured":"Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Amir O, Freedman L, et al. Protection by a fourth dose of BNT162b2 against Omicron in Israel. N Engl J Med. 2022;386:1712\u201320.","journal-title":"N Engl J Med"},{"key":"1043_CR18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/NEJMoa2204919","volume":"387","author":"R Arbel","year":"2022","unstructured":"Arbel R, Wolff Sagy Y, Hoshen M, Battat E, Lavie G, Sergienko R, et al. Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge. N Engl J Med. 2022;387:790\u20138.","journal-title":"N Engl J Med"},{"key":"1043_CR19","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1016\/S2468-2667(20)30133-X","volume":"5","author":"NG Davies","year":"2020","unstructured":"Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. Lancet Public Health. 2020;5:e375-85.","journal-title":"Lancet Public Health"},{"key":"1043_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12916-022-02606-8","volume":"20","author":"Z Huang","year":"2022","unstructured":"Huang Z, Xu S, Liu J, Wu L, Qiu J, Wang N, et al. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 variant infection, severe illness, and death. BMC Med. 2022;20:400.","journal-title":"BMC Med"},{"key":"1043_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.46234\/ccdcw2022.048","volume":"4","author":"G He","year":"2022","unstructured":"He G, Zeng F, Xiao J, Zhao J, Liu T, Hu J, et al. When and how to adjust non-pharmacological interventions concurrent with booster vaccinations against COVID-19\u2014Guangdong, China, 2022. China CDC Wkly. 2022;4:199\u2013206.","journal-title":"China CDC Wkly"},{"key":"1043_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jiph.2022.03.011","volume":"15","author":"F Zhou","year":"2022","unstructured":"Zhou F, Hu TJ, Zhang XY, Lai K, Chen JH, Zhou XH. The association of intensity and duration of non-pharmacological interventions and implementation of vaccination with COVID-19 infection, death, and excess mortality: natural experiment in 22 European countries. J Infect Public Health. 2022;15:499\u2013507.","journal-title":"J Infect Public Health"},{"key":"1043_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40249-020-00709-z","volume":"9","author":"J Zu","year":"2020","unstructured":"Zu J, Li ML, Li ZF, Shen MW, Xiao YN, Ji FP. Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study. Infect Dis Poverty. 2020;9:83.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/vbz.2021.0023","volume":"21","author":"M Chen","year":"2021","unstructured":"Chen M, Ai L, Huang D, Chen J, Feng T, Mei S, et al. Soaring asymptomatic infected individuals bring about barriers and difficulties for interruption of COVID-19 prevalence in China. Vector Borne Zoonotic Dis. 2021;21:777\u201384.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"1043_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40249-022-00994-w","volume":"11","author":"SX Zhang","year":"2022","unstructured":"Zhang SX, Yang M, Zheng JX, Zhang BQ, Pan CH, Tian LG. Comprehensive strategies and measures to control COVID-19. Infect Dis Poverty. 2022;11:67.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100592","volume":"29","author":"Z Chen","year":"2022","unstructured":"Chen Z, Deng X, Fang L, Sun K, Wu Y, Che T, et al. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study. Lancet Reg Health West Pac. 2022;29: 100592.","journal-title":"Lancet Reg Health West Pac"},{"key":"1043_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jinf.2022.07.006","volume":"85","author":"L Ye","year":"2022","unstructured":"Ye L, Li WF, Shao J, Xu Z, Ju J, Xu H. Fighting Omicron epidemic in China: real-world big data from Fangcang shelter hospital during the outbreak in Shanghai 2022. J Infect. 2022;85:436\u201380.","journal-title":"J Infect"},{"key":"1043_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","volume":"7","author":"Y Fan","year":"2022","unstructured":"Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7:141.","journal-title":"Signal Transduct Target Ther"},{"key":"1043_CR29","doi-asserted-by":"publisher","first-page":"20200283","DOI":"10.1098\/rstb.2020.0283","volume":"376","author":"K Sherratt","year":"2021","unstructured":"Sherratt K, Abbott S, Meakin SR, Hellewell J, Munday JD, Bosse N, et al. Exploring surveillance data biases when estimating the reproduction number: with insights into subpopulation transmission of COVID-19 in England. Philos Trans R Soc Lond B Biol Sci. 2021;376:20200283.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1043_CR30","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3390\/v14071576","volume":"14","author":"S Jin","year":"2022","unstructured":"Jin S, Dickens BL, Lim JT, Cook AR. EpiRegress: a method to estimate and predict the time-varying effective reproduction number. Viruses. 2022;14:1576.","journal-title":"Viruses"},{"key":"1043_CR31","doi-asserted-by":"publisher","first-page":"2000257","DOI":"10.2807\/1560-7917.ES.2020.25.17.2000257","volume":"25","author":"T Ganyani","year":"2020","unstructured":"Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J, et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020;25:2000257.","journal-title":"Euro Surveill"},{"key":"1043_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"SA Lauer","year":"2020","unstructured":"Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172:577\u201382.","journal-title":"Ann Intern Med"},{"key":"1043_CR33","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3201\/eid2809.220613","volume":"28","author":"YM Mefsin","year":"2022","unstructured":"Mefsin YM, Chen D, Bond HS, Lin Y, Cheung JK, Wong JY, et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant, Hong Kong, January\u2013March 2022. Emerg Infect Dis. 2022;28:1856\u20138.","journal-title":"Emerg Infect Dis"},{"key":"1043_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.28008","volume":"5","author":"Y Wu","year":"2022","unstructured":"Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw Open. 2022;5: e2228008.","journal-title":"JAMA Netw Open"},{"key":"1043_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40249-022-01030-7","volume":"11","author":"P Yuan","year":"2022","unstructured":"Yuan P, Tan Y, Yang L, Aruffo E, Ogden NH, Yang G, et al. Assessing the mechanism of citywide test-trace-isolate Zero-COVID policy and exit strategy of COVID-19 pandemic. Infect Dis Poverty. 2022;11:104.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.46234\/ccdcw2022.030","volume":"4","author":"X Li","year":"2022","unstructured":"Li X, Zhang Z, Lyu K, Xu D. Strengthening community defenses to prevent and control the spread of COVID-19 in China. China CDC Wkly. 2022;4:191\u20134.","journal-title":"China CDC Wkly"},{"key":"1043_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100479","volume":"21","author":"C Erikstrup","year":"2022","unstructured":"Erikstrup C, Laksafoss AD, Gladov J, Kaspersen KA, Mikkelsen S, Hindhede L, et al. Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: a nationwide serosurveillance study. Lancet Reg Health Eur. 2022;21: 100479.","journal-title":"Lancet Reg Health Eur"},{"key":"1043_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437\u201346.","journal-title":"Lancet"},{"key":"1043_CR39","unstructured":"COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020\u201321. Lancet. 2022;399:1513\u201336."},{"key":"1043_CR40","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","volume":"400","author":"AV Ballering","year":"2022","unstructured":"Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452\u201361.","journal-title":"Lancet"},{"key":"1043_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2022.114762","volume":"296","author":"R Jain","year":"2022","unstructured":"Jain R, Dupas P. The effects of India\u2019s COVID-19 lockdown on critical non-COVID health care and outcomes: evidence from dialysis patients. Soc Sci Med. 2022;296: 114762.","journal-title":"Soc Sci Med"},{"key":"1043_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40249-020-00714-2","volume":"9","author":"H Zou","year":"2020","unstructured":"Zou H, Shu Y, Feng T. How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19. Infect Dis Poverty. 2020;9:89.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40249-022-01019-2","volume":"11","author":"L Kong","year":"2022","unstructured":"Kong L, Duan M, Shi J, Hong J, Zhou X, Yang X, et al. Optimization of COVID-19 prevention and control measures during the Beijing 2022 Winter Olympics: a model-based study. Infect Dis Poverty. 2022;11:95.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR44","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S1473-3099(20)30457-6","volume":"20","author":"AJ Kucharski","year":"2020","unstructured":"Kucharski AJ, Klepac P, Conlan AJK, Kissler SM, Tang ML, Fry H, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020;20:1151\u201360.","journal-title":"Lancet Infect Dis"},{"key":"1043_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01840-2","author":"T Lefran\u00e7ois","year":"2022","unstructured":"Lefran\u00e7ois T, Malvy D, Atlani-Duault L, Benamouzig D, Druais PL, Yazdanpanah Y, et al. After 2 years of the COVID-19 pandemic, translating One Health into action is urgent. Lancet. 2022. https:\/\/doi.org\/10.1016\/S0140-6736(22)01840-2.","journal-title":"Lancet"},{"key":"1043_CR46","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(20)32007-9","volume":"396","author":"E Han","year":"2020","unstructured":"Han E, Tan MMJ, Turk E, Sridhar D, Leung GM, Shibuya K, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525\u201334.","journal-title":"Lancet"},{"key":"1043_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/09514848221080687","author":"A Gandjour","year":"2022","unstructured":"Gandjour A. Cost-effectiveness of future lockdown policies against the COVID-19 pandemic. Health Serv Manage Res. 2022. https:\/\/doi.org\/10.1177\/09514848221080687.","journal-title":"Health Serv Manage Res"},{"key":"1043_CR48","doi-asserted-by":"crossref","unstructured":"Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C, Fitzmaurice KP, et al. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Health. 2021;9:e120\u201329.","DOI":"10.1016\/S2214-109X(20)30452-6"},{"key":"1043_CR49","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.tree.2020.05.004","volume":"35","author":"MA Nu\u00f1ez","year":"2020","unstructured":"Nu\u00f1ez MA, Pauchard A, Ricciardi A. Invasion science and the global spread of SARS-CoV-2. Trends Ecol Evol. 2020;35:642\u20135.","journal-title":"Trends Ecol Evol"},{"key":"1043_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40249-022-00979-9","volume":"11","author":"SW Fei","year":"2022","unstructured":"Fei SW, Gu SY, Chen FM, Zhou N, Cheng ZL, Xie Y, et al. Towards a global One Health index: a potential assessment tool for One Health performance. Infect Dis Poverty. 2022;11:57.","journal-title":"Infect Dis Poverty"},{"key":"1043_CR51","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1080\/22221751.2022.2125343","volume":"11","author":"Q Li","year":"2022","unstructured":"Li Q, Bergquist R, Grant L, Song JX, Feng XY, Zhou XN. Consideration of COVID-19 beyond the human-centred approach of prevention and control: the ONE-HEALTH perspective. Emerg Microb Infect. 2022;11:2520\u20138.","journal-title":"Emerg Microb Infect"},{"issue":"7907","key":"1043_CR52","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/d41586-022-01108-0","volume":"604","author":"XX Zhang","year":"2022","unstructured":"Zhang XX, Liu JS, Han LF, Simm G, Guo XK, Zhou XN. One Health: new evaluation framework launched. Nature. 2022;604(7907):625.","journal-title":"Nature"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-022-01043-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-022-01043-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-022-01043-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T13:10:50Z","timestamp":1669381850000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-022-01043-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1043"],"URL":"https:\/\/doi.org\/10.1186\/s40249-022-01043-2","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}